Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan
Crossref DOI link: https://doi.org/10.1007/s12325-018-0859-x
Published Online: 2018-12-27
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Omboni, Stefano http://orcid.org/0000-0002-7124-2096
Volpe, Massimo http://orcid.org/0000-0002-9642-8380
Text and Data Mining valid from 2018-12-27
Article History
Received: 2 October 2018
First Online: 27 December 2018